We are live on
!
Find out more
KCM
Kalehua Capital Management Portfolio holdings
AUM
$174M
This Fund
S&P 500
This Quarter
Est. Return
+26.81%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$97.9M
Cap. Flow
% of AUM
96.83%
Top 10 Holdings %
Top 10 Hldgs %
83.53%
Holding
19
New
19
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alpha Architect 1-3 Month Box ETF
BOXX
|
+$26.4M |
| 2 |
X4 Pharmaceuticals
XFOR
|
+$13.5M |
| 3 |
SION
Sionna Therapeutics
SION
|
+$7.47M |
| 4 |
Relay Therapeutics
RLAY
|
+$6.43M |
| 5 |
Surrozen
SRZN
|
+$6.23M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.73% |
| 2 | Miscellaneous | 26.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Alpha Architect 1-3 Month Box ETF
BOXX
$14.6B
| $26.6M | 26.27% |
+230,787
| New | +$26.4M |
2025 Q4
0 quarters
|
|
|
2
X4 Pharmaceuticals
XFOR
$289M
| $14.9M | 14.73% |
+3,722,840
| New | +$13.5M |
2025 Q4
0 quarters
|
|
|
SION
3
Sionna Therapeutics
SION
$222M
| $8.11M | 8.02% |
+197,072
| New | +$7.47M |
2025 Q4
0 quarters
|
|
|
4
Relay Therapeutics
RLAY
$3.92B
| $7.63M | 7.54% |
+901,457
| New | +$6.43M |
2025 Q4
0 quarters
|
|
|
CMPS
5
Compass Pathways
CMPS
$1.66B
| $5.66M | 5.59% |
+819,692
| New | +$5M |
2025 Q4
0 quarters
|
|
6
Pharvaris
PHVS
$2.18B
| $5.52M | 5.46% |
+198,772
| New | +$4.79M |
2025 Q4
0 quarters
|
|
|
SEPN
7
Septerna Inc
SEPN
$1.79B
| $5.42M | 5.36% |
+194,544
| New | +$4.65M |
2025 Q4
0 quarters
|
|
|
ORKA
8
Oruka Therapeutics
ORKA
$5.44B
| $3.59M | 3.55% |
+118,524
| New | +$3.3M |
2025 Q4
0 quarters
|
|
9
Inhibikase Therapeutics
IKT
$275M
| $3.59M | 3.55% |
+1,750,000
| New | +$2.78M |
2025 Q4
0 quarters
|
|
10
Allogene Therapeutics
ALLO
$504M
| $3.49M | 3.45% |
+2,546,129
| New | +$3.36M |
2025 Q4
0 quarters
|
|
|
LONA
11
LeonaBio Inc
LONA
$54.2M
| $2.98M | 2.95% |
+393,701
| New | +$1.8M |
2025 Q4
0 quarters
|
|
12
MoonLake Immunotherapeutics
MLTX
$921M
| $2.32M | 2.29% |
+175,734
| New | +$2.07M |
2025 Q4
0 quarters
|
|
13
Oric Pharmaceuticals
ORIC
$1.24B
| $2.18M | 2.16% |
+267,059
| New | +$3.07M |
2025 Q4
0 quarters
|
|
14
Verrica Pharmaceuticals
VRCA
$70.6M
| $1.96M | 1.94% |
+235,779
| New | +$1.31M |
2025 Q4
0 quarters
|
|
15
Tyra Biosciences
TYRA
$1.37B
| $1.96M | 1.94% |
+74,465
| New | +$1.37M |
2025 Q4
0 quarters
|
|
|
16
Surrozen
SRZN
$349M
| $1.89M | 1.87% |
+385,178
| New | +$6.23M |
2025 Q4
0 quarters
|
|
17
Tenaya Therapeutics
TNYA
$130M
| $1.42M | 1.41% |
+2,000,000
| New | +$2.72M |
2025 Q4
0 quarters
|
|
|
KLRS
18
Kalaris Therapeutics
KLRS
$56.2M
| $1.18M | 1.17% |
+139,901
| New | +$895K |
2025 Q4
0 quarters
|
|
19
DiaMedica Therapeutics
DMAC
$449M
| $759K | 0.75% |
+95,359
| New | +$713K |
2025 Q4
0 quarters
|
|
Similar funds
PWSG
6SA
NWA
PIA
CPCP
PMSA
MCM
AIA
Kalehua Capital Management's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Kalehua Capital Management, which disclosed 19 positions worth $101M. Its ten largest holdings account for 84% of the portfolio.
Its largest position is Alpha Architect 1-3 Month Box ETF: 230,787 shares worth $26.6M.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, followed by Miscellaneous.
- Kalehua Capital Management's largest Q4 2025 buy was Alpha Architect 1-3 Month Box ETF: 230,787 shares worth $26.6M.
- Kalehua Capital Management's ten largest holdings make up 84% of its $101M portfolio in Q4 2025.
- Kalehua Capital Management disclosed 19 positions in Q4 2025, its first 13F filing on record.
Based on Kalehua Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.